Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate - PubMed (original) (raw)
- PMID: 6122503
Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate
S H Yuspa et al. Cancer Res. 1982 Jun.
Abstract
Mouse epidermal basal cells can be selectively cultivated in medium with 0.02 to 0.09 mM Ca2+ and can be induced to differentiate by medium containing 1.2 mM Ca2+. Basal cell cultures were studied to determine if all cells in this population responded identically to the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Studies on the induction of the enzyme epidermal transglutaminase by TPA demonstrated a 2- to 4-fold increase in activity within 12 hr of exposure. This activity increase paralleled morphological differentiation in approximately 50% of the basal cell population, and differentiating cells sloughed from the culture dish within 24 to 48 hr as transglutaminase activity returned to basal levels. The cells which remained were resistant to induced differentiation by 1.2 mM Ca2+ medium, in that they failed to demonstrate increased transglutaminase activity or decreased thymidine incorporation, both characteristics of control basal cells induced to differentiate by 1.2 mM Ca2+. Cells remaining after a single exposure to TPA did not respond to a second exposure with an induction of transglutaminase if the interval between exposures was 4 days. TPA-pretreated cells did not undergo a transient decrease in thymidine incorporation (characteristic of control cells) when exposed to TPA a second time but instead were directly stimulated to proliferate by the phorbol ester, indicating that such cells were not refractory to the promoter. When the treatment-free interval after TPA was extended from 4 to 10 days, transglutaminase inducibility was restored in basal cells to either TPA or 1.2 mM Ca2+ as inducers. These results indicate that heterogeneity exits within the epidermal cell population and that exposure to phorbol esters induces differentiation in some cells, while stimulating proliferation in others. Such heterogeneous responses would cause a selective redistribution of the epidermal cell population and could lead to clonal expansion of initiated cells.
Similar articles
- Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH, Hennings H, Lichti U. Yuspa SH, et al. J Supramol Struct Cell Biochem. 1981;17(3):245-57. doi: 10.1002/jsscb.380170306. J Supramol Struct Cell Biochem. 1981. PMID: 7328673 - Regulation of epidermal transglutaminase activity and terminal differentiation by retinoids and phorbol esters.
Yuspa SH, Ben T, Lichti U. Yuspa SH, et al. Cancer Res. 1983 Dec;43(12 Pt 1):5707-12. Cancer Res. 1983. PMID: 6139162 - Molecular and cellular basis for tumor promotion in mouse skin.
Yuspa SH. Yuspa SH. Princess Takamatsu Symp. 1983;14:315-26. Princess Takamatsu Symp. 1983. PMID: 6394593 Review.
Cited by
- TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2.
Ku AT, Shaver TM, Rao AS, Howard JM, Rodriguez CN, Miao Q, Garcia G, Le D, Yang D, Borowiak M, Cohen DN, Chitsazzadeh V, Diwan AH, Tsai KY, Nguyen H. Ku AT, et al. Elife. 2017 May 3;6:e23242. doi: 10.7554/eLife.23242. Elife. 2017. PMID: 28467300 Free PMC article. - Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
Kelsey JS, Cataisson C, Chen J, Herrmann MA, Petersen ME, Baumann DO, McGowan KM, Yuspa SH, Keck GE, Blumberg PM. Kelsey JS, et al. Mol Carcinog. 2016 Dec;55(12):2183-2195. doi: 10.1002/mc.22460. Epub 2016 Feb 9. Mol Carcinog. 2016. PMID: 26859836 Free PMC article. - Distinct effects of different phosphatidylglycerol species on mouse keratinocyte proliferation.
Xie D, Seremwe M, Edwards JG, Podolsky R, Bollag WB. Xie D, et al. PLoS One. 2014 Sep 18;9(9):e107119. doi: 10.1371/journal.pone.0107119. eCollection 2014. PLoS One. 2014. PMID: 25233484 Free PMC article. - Calcium regulation of keratinocyte differentiation.
Bikle DD, Xie Z, Tu CL. Bikle DD, et al. Expert Rev Endocrinol Metab. 2012 Jul;7(4):461-472. doi: 10.1586/eem.12.34. Expert Rev Endocrinol Metab. 2012. PMID: 23144648 Free PMC article. - Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS.
Markell LM, Masiuk KE, Blazanin N, Glick AB. Markell LM, et al. Mol Cancer Res. 2011 Jun;9(6):746-56. doi: 10.1158/1541-7786.MCR-11-0112. Epub 2011 Apr 26. Mol Cancer Res. 2011. PMID: 21521744 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous